Lender Provides $1M Loan, Takes Board Control Amid Going Concern
BRTX has more than doubled off its 52-week low of $0.159 on light trading volume (0.1× avg).
Summary
BioRestorative Therapies obtained a $1 million high-interest loan, ceding board control to the lender, as it seeks to fund a larger equity offering to address its going concern warning.
Key Events · Financing and Capital Events · BRTX
-
Secured $1 Million Revolving Loan
The company entered into a revolving loan agreement with Bowery Group LLC for up to $1,000,000 at a 12% annual interest rate, with a 16% default rate. This loan provides immediate, albeit costly, liquidity.
-
Lender Gains Board Control
Three existing directors (Francisco Silva, Nickolay Kukekov, Patrick F. Williams) resigned, and three new directors (Mika Grasso, Katharyn Field, Jatinder Dhaliwal) designated by the lender were appointed to the board, effective June 12, 2026.
-
Contingent Director Tenure
The new directors' positions are contingent on the company completing a Qualified Public Equity Offering (at least $5M) by July 17, 2026, and a Required Additional Financing (at least $10M total) within 120 days, giving the lender significant leverage.
-
Financing for Future Equity Offering
Proceeds from the loan are intended for general corporate purposes, including financing the expense of a Qualified Public Equity Offering, following a recent shareholder approval to increase authorized shares to 1.5 billion.
Analysis · BRTX · Industrial Applications And Services
BioRestorative Therapies, a micro-cap company facing a going concern warning, secured a $1 million revolving loan at a high 12% interest rate. This financing is critical for short-term liquidity and explicitly intended to fund a future, larger public equity offering. In exchange for the loan, the lender gained significant control, appointing three new directors to the board while three existing directors resigned. The new directors' tenure is contingent on the company successfully completing the planned equity offerings, highlighting the company's urgent need for capital and the lender's strong influence over its future financing strategy.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRTX was trading at $0.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9M. The 52-week trading range was $0.16 to $2.05. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.